Associated Press (01/12/12)
CVS Caremark will pay $5 million to resolve allegations that one of its subsidiaries understated the price of several drugs. The payment will be used to reimburse Medicare prescription drug beneficiaries who paid more than they expected for the drugs. VS Caremark said its Rx America business accidentally published incorrect drug price information on a site maintained by Medicare. The FTC said the inaccurate information was also posted on third-party websites, and it was online from 2007 through at least November 2008. The agency said that the RxAmerica price listings were deceptive and that many Medicare beneficiaries chose RxAmerica plans because of those prices. In some cases, the actual prices were 10 times higher than the listed prices. The drugs were sold at CVS and Walgreen stores.

Read the complete article